While the Supreme Court analyzes the technical legal standing of pro-life doctors to sue the Food and Drug Administration over the chemical abortion pill mifepristone, the case holds the potential to highlight the health dangers to women posed by the drug and its politically prompted approval ("Supreme Court justices weigh rolling back use of the abortion pill," Web, March 26).
